AI Science Tracker

A1: deep learning identifies an antibiotic candidate against gonorrhea

MIT; Karolinska Institutet, and collaborators · 22 Jun 2026 · medicine

Discovery

A1: deep learning identifies an antibiotic candidate against gonorrhea

A screen of about six million compounds found candidates active against resistant Neisseria gonorrhoeae. A1 reduced bacteria in animal models, and proteomics, genetics, and biochemistry confirmed its target, alanine racemase. These are preclinical results, published in Science Translational Medicine.

Technology: Deep learning for molecule screening

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Phenotypic screen of 38,650 molecules trained a graph neural network, which screened about 6 million compounds; 213 were validated experimentally, 83 inhibited growth. Two hits were tested in vitro against multidrug-resistant strains, by proteomics (alanine racemase target), in a vagina-on-a-chip model and in a mouse vaginal infection model.
  • Still unknown: Not reported (the abstract describes the in vivo and organ-chip results as showing only early promise).
  • AI role: A graph neural network trained on phenotypic screening data, used to virtually screen the compound library before experimental validation.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1126/scitranslmed.ads4699&resultType=core&format=json · https://news.ki.se/ai-helps-identify-new-antibiotic-candidates-against-drug-resistant-gonorrhoea

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.